Two types of indirect diagnostics are recommended to detect individuals who might benefit from TB preventive treatment: purified protein derivative (PPD) tuberculin skin test (TST) and interferon-gamma release assays (IGRA).1 This evidence concerns the gene IFNG and tuberculosis.